BMO Capital Upgrades Boston Scientific To Outperform

Analysts at BMO Capital upgraded

from Market Perform to Outperform. The price target for Boston Scientific has been raised from $15.00 to $18.00. Boston Scientific shares have gained 9.76% over the past 52 weeks, while the S&P 500 index has surged 13.39% in the same period. Boston Scientific shares rose 0.34% to $14.90 in pre-market trading.